Cargando…

Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection

BACKGROUND: Latent tuberculosis infection (LTBI) has been associated with increased immune activation. We assessed circulating concentrations of interferon-gamma in persons with LTBI. METHODS: We used the 2011-2012 National Health Nutritional Examination Survey (NHANES) to identify adults with and w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huaman, Moises A., Deepe, George S., Fichtenbaum, Carl J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pathogens and Immunity 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108047/ https://www.ncbi.nlm.nih.gov/pubmed/27853753 http://dx.doi.org/10.20411/pai.v1i2.149

Ejemplares similares

Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru
por: Huaman, Moises A., et al.
Publicado: (2018)

Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection
por: Feria, Manuel G, et al.
Publicado: (2022)

1648. CD4 T Lymphocyte and Monocyte Activation within One Year After Treatment Completion for Pulmonary Tuberculosis: A Pilot Study
por: Huaman, Moises A, et al.
Publicado: (2020)

3280 Mycobacterium bovis Bacille-Calmette-Guérin infection aggravates atherosclerosis
por: Huaman, Moises, et al.
Publicado: (2019)

Circulating granulysin levels in healthcare workers and latent tuberculosis infection estimated using interferon-gamma release assays
por: Thuong, Pham Huu, et al.
Publicado: (2016)

Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
por: Doan, Tan N., et al.
Publicado: (2017)

Cytomegalovirus Infection Is Associated With Increased Prevalence of Latent Tuberculosis Infection
por: van der Heijden, Yuri F, et al.
Publicado: (2021)

Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis
por: Huaman, Moises A., et al.
Publicado: (2020)

Validation and Clinical Application of Interferon-Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection in Children
por: Benachinmardi, Kirtilaxmi K, et al.
Publicado: (2019)

The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South Korea
por: Jang, Ju Young, et al.
Publicado: (2014)

Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012)

Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays
por: Talati, Naasha J, et al.
Publicado: (2011)

Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents
por: Kim, Kyeong-Hee, et al.
Publicado: (2011)

Levels of Interferon-Gamma Increase after Treatment for Latent Tuberculosis Infection in a High-Transmission Setting
por: Takenami, Iukary, et al.
Publicado: (2012)

Interferon Gamma-Based Detection of Latent Tuberculosis Infection in the Border States of Nuevo Leon and Tamaulipas, Mexico
por: Oren, Eyal, et al.
Publicado: (2015)

Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients
por: Wang, Ping-Huai, et al.
Publicado: (2020)

Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection
por: Park, Heechul, et al.
Publicado: (2022)

Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma
por: Tincati, Camilla, et al.
Publicado: (2012)

Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence
por: Trajman, A., et al.
Publicado: (2013)

Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people
por: Scordo, Julia M., et al.
Publicado: (2021)

Latent Tuberculosis Infection and Elevated Incidence of Hypertension
por: Mandieka, Edwin, et al.
Publicado: (2020)

The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda
por: Biraro, Irene Andia, et al.
Publicado: (2016)

Evaluation of role of interferon gamma release assays in the diagnosis of latent tuberculosis in human immunodeficiency virus-infected patients
por: Singh, Rajender, et al.
Publicado: (2021)

Utility of the Interferon-Gamma Release Assay for Latent Tuberculosis Infection Screening among Indian Health-Care Workers
por: Girish, Sunita, et al.
Publicado: (2021)

Evaluation of a New Chemiluminescent Immunoassay-Based Interferon-Gamma Release Assay for Detection of Latent Tuberculosis Infection
por: Kim, Keun Ju, et al.
Publicado: (2023)

1476 Screening for Latent Tuberculosis Infection in Internationally Adopted Children in the era of Interferon-Gamma Release Assay (IGRA) Testing
por: Dhar, Cherie Priya, et al.
Publicado: (2014)

Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?
por: Jung, Jaewan, et al.
Publicado: (2021)

Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil
por: Kussen, Gislene Maria Botão, et al.
Publicado: (2015)

Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis
por: Zhou, Guozhong, et al.
Publicado: (2023)

Tuberculin Skin Testing and Treatment Modulates Interferon-Gamma Release Assay Results for Latent Tuberculosis in Migrants
por: O'Shea, Matthew K., et al.
Publicado: (2014)

Risk Factors for Indeterminate Outcome on Interferon Gamma Release Assay in Non-US-Born Persons Screened for Latent Tuberculosis Infection
por: Sharninghausen, Jody C, et al.
Publicado: (2018)

1377. Use of Interferon-Gamma Release Assays (IGRAs) Reduced Latent Tuberculosis Infection (LTBI) Diagnosis in Refugee and Immigrant Children
por: Kushner, Lauren E, et al.
Publicado: (2019)

Therapeutic potential of interferon-gamma in tuberculosis
por: Berns, Svetlana A., et al.
Publicado: (2022)

Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis
por: Auguste, Peter, et al.
Publicado: (2017)

Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection
por: Kang, Yun-Jeong, et al.
Publicado: (2021)

Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis
por: Qiu, Xia, et al.
Publicado: (2019)

Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis
por: Agarwal, Sanjay K., et al.
Publicado: (2015)

Diagnosis of latent tuberculosis among HIV infected patients in Ilorin, Nigeria using tuberculin skin test and interferon gamma release assay
por: Aladesanmi, Adeniyi Olatunji, et al.
Publicado: (2021)

Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort
por: Kim, Hyung Woo, et al.
Publicado: (2021)

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_4sevuf7m83vp2pfg4s75jcqb6p